# Pliant Therapeutics, Inc.: Form 8-K, filed Sep 26, 2023

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2023-09-26
- Accepted by EDGAR: Sep 26, 2023, 07:34 ET
- Period: 2023-09-26
- Accession: 0001193125-23-241849
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000119312523241849/d473253d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000119312523241849/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000119312523241849/d473253d8k.htm

Filed Sep 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-241849. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
